DEVRO PLC — Board/Management Information 2021

Nov 2, 2021

National Storage Mechanism | Additional information

RNS Number : 9872Q

Devro PLC

02 November 2021

2 November 2021

DEVRO PLC

Directorate Changes

Devro plc ("Devro" or the "Company"), one of the world's leading manufacturers of collagen products for the food industry is pleased to announce the appointment of Rikke Mikkelsen as an independent non-executive director of the Company with effect from 1 December 2021.  Rikke will also become a member of the Audit, Remuneration and Nomination Committees from that date.

Rikke, a chemical engineer, currently leads the Global Centre of Excellence for Chocolate and Confectionary and the European Customer Innovation team at Scandinavian-headquartered AAK A/S, which specialises in the development of value-adding ingredients for global consumer food and nutrition products.  Rikke's role at AAK is the most recent position in a broad-ranging career spanning over 30 years in research and development with global companies focused on delivering innovative solutions in the food sector.  Rikke is a Danish national.

Rikke will succeed Chantal Cayuela who has decided, on personal grounds, to retire as a non-executive director of the Company with effect from 30 November 2021.

Steve Good, Devro's Chairman, said:

"I am delighted to welcome Rikke to Devro's Board of Directors. She brings extensive experience of successful product innovation in international food manufacturing businesses and will add valuable skills and insights to support the further development and execution of the Company's growth strategy.  On behalf of the Board, I also want to thank Chantal for her important contribution during her short time with us and wish her well for the future."

Nothing in connection with Rikke's appointment falls to be disclosed under LR 9.6.13.

ENDS

Contacts:

Devro plc

Steve Good	Chairman	Tel: 020 3865 7637

FTI Consulting

Richard Mountain		Tel: 020 3727 1340

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

BOAUPGQPGUPGGRG